HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SD-208

selective and potent orally active TGF-beta receptor I kinase inhibitor
Networked: 19 relevant articles (2 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Medicherla, Satyanarayana: 5 articles (11/2008 - 11/2006)
2. Higgins, Linda S: 5 articles (10/2008 - 11/2004)
3. Murphy, Alison: 5 articles (07/2007 - 11/2004)
4. Protter, Andrew A: 4 articles (11/2008 - 08/2006)
5. Kapoun, Ann M: 4 articles (10/2008 - 08/2006)
6. Guise, Theresa A: 3 articles (04/2015 - 01/2011)
7. Mohammad, Khalid S: 3 articles (04/2015 - 01/2011)
8. Gaspar, Nicholas J: 3 articles (11/2007 - 08/2006)
9. Ma, Jing Ying: 3 articles (11/2007 - 11/2004)
10. Wong, Darren H: 3 articles (11/2007 - 11/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Adenocarcinoma
4. Prostatic Neoplasms (Prostate Cancer)
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Transforming Growth Factor beta (TGF-beta)
3. Adenosine Triphosphate (ATP)
4. Transforming Growth Factor beta Receptors (TGF beta Receptors)
5. TGF-beta type I receptor
6. Transforming Growth Factor beta1 (TGF beta 1)
7. Transforming Growth Factor beta2
8. Parathyroid Hormone-Related Protein
9. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
10. MicroRNAs (MicroRNA)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Homologous Transplantation (Allograft)
3. Ligation
4. Oral Administration